Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis
JAMA Cardiology 10.1001/jamacardio.2026.0654April 15, 2026 at 11:00 AM EDT
In asymptomatic patients with severe aortic stenosis, is myocardial fibrosis burden associated with adverse events and potential benefits of early valve intervention?In this post hoc analysis of a randomized clinical trial, higher midwall fibrosis burden was associated with increasing incidence of the primary composite end point of all-cause death or unplanned aortic stenosis–related hospitalization. However, the potential beneficial effects of early valve intervention demonstrated no significant heterogeneity by the degree of midwall fibrosis.In this study, in asymptomatic patients with severe aortic stenosis, higher fibrosis burden was associated with adverse outcomes; benefits of early intervention were similar between patients with high and low fibrosis burden.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.